Navigation Links
BMEYE B.V. Completes EUR 6 Million Series B Financing Round
Date:10/8/2009

> About 360 Capital Partners

360 Capital Partners is a Venture Capital firm, investing in Innovation at full scale, in Europe. 360 Capital Partners is managed by a consolidated team which has cumulated 50+ years of Venture Capital experience in investing in, following-up and/or exiting from over 60 companies and which have more than EUR200 million under management, provided by top tier international investors. 360 Capital Partners leverages an important international network, it co-invested with major international Venture Capital funds in 10 countries and have proven a top quartile track record as individuals and as a team in very different economic environments

About LSP

LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing to private and public life-science companies. Since the late 1980s, LSP's management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. For example, LSP was a founding investor in Crucell, DNage, Qiagen, Rhein Biotech and Pharming. With over EUR 500 million under management and offices in Amsterdam, Munich and Boston, LSP is one of Europe's largest and most experienced life-science investors.

Further information is available at http://www.lspvc.com.

SOURCE BMEYE B.V.


'/>"/>
SOURCE BMEYE B.V.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary, Sanvita, Inc.
2. DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm
3. Tetraphase Pharmaceuticals Completes Series B Financing to Support the Advancement of Novel Antibiotic Drug Candidates
4. PDL BioPharma Completes October 1 Special Dividend Payment
5. SyntheMed Completes $1.0 Million Equity Placement
6. ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures
7. ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
8. ANAVEX completes scale-up manufacturing of ANAVEX 2-73 for Phase I Alzheimers disease clinical trials
9. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
10. Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
11. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Pipettes & Pipettors - A Global Market Per...4373/Pipettes--Pipettors---A-Global-Market-Perspec...amp;utm_campaign=prnewswire ,, Pipettes and p...search laboratory. Large-scale applications in lif...
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Global Markets for Assisted Reproductive Devic...742/Global-Markets-for-Assisted-Reproductive-Devic...pr&utm_campaign=prnewswire ,, Global Mark...Countries in Europe and Japan. This report include...
(Date:11/20/2009)...rstCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL)...tember 30, 2009 with net earnings of $128,000, or .... This compares to net earnings of $328,000, or $...for the first quarter of last year. ,, Commenti...and CEO Steve Springrose said: "Biotel enjoyed str...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Biotel Announced Profitable First Quarter Ended September 30, 2009 2IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 1IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 2Health Robotics Receives Overwhelming Support from its Customers for its McKesson CytoCare Partnership 13664 1Health Robotics Receives Overwhelming Support from its Customers for its McKesson CytoCare Partnership 13664 2Health Robotics Receives Overwhelming Support from its Customers for its McKesson CytoCare Partnership 13664 3Health Robotics Receives Overwhelming Support from its Customers for its McKesson CytoCare Partnership 13664 4Aurora B answers an XIST ential question 9679 1Aurora B answers an XIST ential question 9679 2
...c treatment with chemotherapy and pegylated enzyme...red to chemotherapy alone - - Peg...2 Halozyme Therapeutics,Inc. (Nasdaq: HALO ), a ...lizing products targeting the extracellular matrix...-clinical animal efficacy data,for its pegylated-r...
...o Launch Innovative Laser Lipolysis Technology in ..., WESTFORD, Mass., July 22 Cynosure, Inc.,(Nasda...f a broad array of,light-based aesthetic treatment...artlipo MPX(TM), the company,s high-powered, dual-...d tighten skin through collagen,remodeling. The CE...
Other Medicine Technology:Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3
(Date:11/21/2009)... New Haven Dental Group merges their practice wi...T. , (PRWEB) November 21,...partners Dr. David Gibson, Dr. Dean Cloutier, Dr. ...erged their growing practice with that of esteemed...kman decided he wanted to retire from dentistry in...
(Date:11/20/2009)...eurologist Closer to Understanding Brain Wiring an...SNewswire/ -- Dr. Jeremy Schmahmann, Professor of ...t at the Massachusetts General Hospital in Boston,...y,s research on the new field of study called "Con...n. ,, Dr. Schmahmann is an award-winning leader...
(Date:11/20/2009)..., Nov. 20 The American...ify health care reform legislation released this w...h insurance individual coverage mandate. The actua...e will minimize adverse selection stemming from mo...y the bill. ,, "The individual mandate language...
(Date:11/20/2009)...., Nov. 20 Following a recall by U...moved from sale Shedd,s Country Crock ® Side ...untry Crock ® Side Dishes DELUXE Four Cheese ..., The following code dates and UPCs are affected: ...LUXE Cheddar Broccoli Rice 21 oz, UPC 027400218316...
(Date:11/20/2009)...N.J., Nov. 20 Rates of i... peaked in late October, but the pandemic flu viru... all age groups, including the elderly, according ...(NYSE: DGX ), the world,s leading provider of di... In its most recent Quest Diagnostics Health Trend...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
... drug that might prove useful in developing treatm...ublished by Cell Press in the July 8 issue of the ...of one of the most frequently disrupted tumor supp...athological conditions. , "The cyclin kinase inhi...
...icine,attempts to treat menopausal symptoms with d...lying causes. As a result, menopausal women may ha...ugh Holistic Health Solutions, a,woman may signifi...auses,of a health problem instead of just masking ...
...E: HSP ), a global specialty pharmaceutical and m...t will host a conference call to discuss its,secon... at 8 a.m. Central,time., The company will releas...will be available on Hospira,s,Web site at http:/...
...inhibits abnormal cells, study finds , , M... in red grapes and red wine suppresses abnormal ce...ncer, according to U.S. researchers. , The compoun...e of disease, a person,s genes, and other factors....
...od Pressure, NASHVILLE, Tenn., July 7 A new arti... such as potassium, and possibly magnesium,and cal...blood pressure and,decrease blood pressure in peop...blished in a supplement appearing with the,July is...
...ire/ -- BMP Sunstone,Corporation (Nasdaq: BJGP; ,B...t it received the New Business License for BMP Sun...n investment in the People,s,Republic of China, fr...ent of Shanghai Rongheng Pharmaceutical Co.,Ltd. (...
Other Medicine News:Health News:Bacterial peptide provides new insight into common tumor suppressor 2Health News:Holistic Health Solutions Offers a Long Awaited Relief for Menopausal Symptoms 2Health News:Dietary Supplement May Prevent Breast Cancer 2Health News:Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 2Health News:Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 3Health News:BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd 2
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: